{"disease":{"id":"newly-diagnosed-glioblastoma-multiforme","name":"newly diagnosed glioblastoma multiforme"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06649851","title":"G-CSF After Chemo-radiation in Patients With Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01591577","title":"Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT07143812","title":"A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"CHA University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}